Stay updated with breaking news from Eye Physicians. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose of atropine, a drug used to dilate pupils, was better than a placebo at limiting eyeglass prescription changes and inhibiting elongation of the eye in nearsighted children aged 6 to 10.
David Wallace, MD, MPH, the Marilyn K. Glick Professor and chair of the Department of Ophthalmology for Indiana University School of Medicine, is new chairman of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute for Vanderbilt University Medical Center.
It’s no secret that today’s society is ever-changing toward the bigger and more industrialized and often less personalized. Medical care – an area that involve
We all want the same thing from our medical care — the utmost safety, highest trained specialists treating us, and the best possible outcomes — especially when it comes to surgery. Safety is our most
The Alabama Academy of Eye Physicians and Surgeons is imploring citizens of the Yellowhammer State to practice caution when selecting eye drops.